Avian infectious bronchitis (IB) is an acute and highly infect-contagious viral disease, responsible by significant economic loss to the poultry industry worldwide that is caused by avian infectious bronchitis virus (IBV) \[[@r6]\]. IBV genome is well known to be highly prone to undergo mutations, leading to changes on nucleotide and/or amino acids sequences of the major structural IBV genes/proteins, resulting in multiple variants of this virus. Most important target of mutations is the spike 1 (S1) glycoprotein gene, especially those located in HVR I, (region encoding amino acid residues 56--69), and HVR II (region encoding amino acid residues 117--131). These regions of S1 glycoprotein have sites involved on the virus attachment to the receptors in the target host cells and the most important neutralizing epitopes. Mutations in the S gene could result in antigenic changes and emergence of IBV variants. This constant arising of new IB variants in different countries \[[@r8], [@r18]\] is usually pointed as the main cause of vaccine failures in the field and constitutes a great challenge for the molecular direct diagnosis of IBV.

Variants of IBV are mutants evolving from parental strains of this virus that differ from strains considered classic, such as those from Massachusetts group, regarding genotype, pathotype, antigenicity and/or immunogenicity. Additionally, IBV mutants are constantly subject to host immune selection and only strains with high antigenic variation are able to evade immune responses induced by vaccines and to survive in the population of hosts, leading to the development of clinical disease \[[@r25]\].

Protection studies between commercial vaccines and IBV variants, especially those using Massachusetts (Mass) vaccines, which is the most common attenuated available vaccine, have demonstrated at least partial cross-protection by some authors \[[@r9], [@r10], [@r12], [@r14], [@r34]\], while another studies have not found cross-protection \[[@r7], [@r35]\].

Therefore, the rapid detection of IBV infection in poultry flocks and its classification between Mass and variants is considered as major challenge, which requires use of appropriate diagnostic methods. To overcome this issue, several rapid assays have been developed focusing on detection and/or characterization of S1 gene of IBV, including direct gene sequencing, RT-PCR methods with serotype-specific primers, and RT-PCR/RFLP, have become widely used, because their results correlated well with the virus-serotyping \[[@r19], [@r21], [@r22], [@r33]\]. Beside these molecular methods, RT-qPCR methods using primers and probes for S1 gene or UTR region were developed and applied for IBV diagnosis, resulting in high sensitivity and specificity \[[@r5]\]. A SYBR Green RT-qPCR was tested on a wide range of coronaviruses and clinical samples, but it was not able to discriminate the different virus genus or strains \[[@r11]\]. Alternatively, a RT-qPCR based on the 3′-UTR of IBV (RT-PCR/HRM curve analysis model), could detect and rapidly distinguish novel and vaccine-related IBV strains from Australia \[[@r15]\]. Finally, a duplex SYBR Green I based RT-qPCR \[[@r1]\] and a RT-qPCR using specific probes \[[@r13], [@r23]\] were able to detect and differentiate Mass and non-Mass strains.

Finally, considering that HVR I and HVR II of S1 gene were thought to be closely associated with major neutralization epitopes and consequently a reliable target for genotyping method, we developed a diagnostic method using Melting Temperature analysis based on these regions aiming to rapid detect and differentiate Mass and non-Mass IBV strains in samples previously isolated and directly in clinical samples. Analytical specificity and sensitivity were also evaluated, and the method was compared to the standard method of virus isolation in embryonated eggs.

Seven reference IBV strains (M41, H120, H52, Ma5, JMK, SE17 and Connecticut) and six Brazilian field isolates (IBVSC01, IBVSC02, IBVPR02, IBVPR03, IBVPR05 and IBVPR07) were provided by Empresa Brasileira de Pesquisa Agropecuária-Embrapa (Concórdia, SC, Brazil) and previously molecularly characterized \[[@r26]\] ([Table 1](#tbl_001){ref-type="table"}Table 1.Avian Infectious Bronchitis virus strains tested by Melting curve analysis using RT-qPCR with SYBR Green I, respective access number in the Genbank, classification of genotype, Tm, fragment length and percentage of GC for HVR I and HVR II regionsS1 regionHVR IHVR IIVirus strainAccession number^a)^Genotype^b)^Tm (°C)bp%GCTm (°C)bp%GCH120M21970Massachusetts81.77 ± 0.06^c)^22841.2377.77 ± 0.12^c)^19132.46H52AF352315Massachusetts81.33 ± 0.06^c)^22841.2377.77 ± 0.12^c)^19131.41Ma5AY561713Massachusetts81.30 ± 0.43^c)^22841.2377.80 ± 0.14^c)^19132.98M41M21883Massachusetts81.77 ± 0.12^c)^22842.5476.16 ± 0.29^d)^19130.37IBVSC01GQ169246Massachusetts81.17 ± 0.20^c)^22840.7977.70 ± 0.00^c)^19132.98IBVPR03GQ169241Massachusetts81.33 ± 0.30^c)^22841.2377.55 ± 0.21^c)^19132.46IBVPR07GQ169244Massachusetts81.33 ± 0.28^c)^22840.7977.63 ± 0.10^c)^19132.98ConnecticutL18990Connecticut80.70 ± 0.10^d)^21639.3577.70 ± 0.05^c)^19131.94IBVSC02GQ169247Connecticut80.60 ± 0.14^d)^21639.3577.70 ± 0.05^c)^19131.94JMKL14070JMK83.40 ± 0.10^e)^22841.6778.15 ± 0.07^e)^20933.97SE 17AF239984SE 1783.70 ± 0.10^e)^22841.2378.25 ± 0.21^e)^21231.60IBVPR02GQ169240Brazilian Variant-B80.30 ± 0.34^d)^21937.9077.60 ± 0.14^c)^21233.49IBVPR05GQ169242Brazilian Variant-C83.17 ± 0.12^e)^22838.6076.90 ± 0.14^f)^21233.96Significant differences between Tm's values were detected by Scott-Knott test and are represented by different letters c--f), with *P*≤0.05. a) Genbank accession number for S1 gene sequence data where available. b) The genotype of each IBV strain had been examined previously by RFLP or nucleotide sequence of S1 gene \[[@r21], [@r26]\].). Three other non-related viruses (commercial vaccines) were also used to confirm specificity of our method: Newcastle disease virus (NDV, La Sota vaccine strain), infectious bursal disease (IBDV, Lukert vaccine strain) and avian metapneumovirus (AMPV, PL-21 vaccine strain).

Ninety-six one-day-old chicks (Cobb-Vantress Lineage) from a commercial broiler chick hatchery were separated in three positive pressure isolators. At 28 days of age, first group (n=42) was experimentally infected by intra-ocular and intranasal routes with 10^5.0^ EID~50~ (50% Embryo Infective Dose) of M41 strain. A negative control group (n=42) was mock infected and maintained under the same conditions. Remaining group (n=12) was inoculated with H120 live attenuated vaccine. Three chickens from the first and second groups were euthanized at 1--10, 12, 15, 17 and 20 days post infection (dpi), while birds from third group were euthanized at 3, 5 e 12 dpi. Trachea and lung samples were collected and kept at −70°C until processing by RNA extraction or virus isolation. Throughout the experimental period, birds received water *ad libitum* and feed once a day, the room temperature was adapted according with bird's age. All procedures have been approved by the Veterinary Sciences Animal Care Committee of Universidade Estadual Paulista, according with ethical principles of animal experimentation adopted by Brazilian College of Experimentation.

Virus isolation in Specific Pathogen Free (SPF) embryonated chicken eggs from tissue samples was performed as previously described \[[@r28]\]. Three passages were conducted to confirm negative samples.

Extraction of RNA from virus strains and tissue samples were performed using Trizol Reagent (Invitrogen, Carlsbad, CA, U.S.A.). The cDNA was synthesized according to instructions provided with SuperScript III Reverse Transcriptase (Invitrogen) and Random Primer (Invitrogen). qPCR was carried out in an Applied Biosystems Real-time 7500 Instrument (Applied Biosystems, Foster City, CA, U.S.A.) using 10 *µl* of Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen), 10 pmol of each primer ([Table 2](#tbl_002){ref-type="table"}Table 2.Sequences of primers used in RT-qPCR for detection of S1 gene of IBVRegionPrimerSequencePosition^b)^ReferenceHVRIC2F-TGG TTG GCA TTT ACA CGG GG20487--20506\[[@r33]\]C3^a)^R-CAA TGT GTA ACA AAC AC20698--20714HVRIIHV+F-GTT ACA CAT TGT TAT AA20704--20720\[[@r27]\]HV−R-ACA AGA TCA CCA TTT AA20878--20894F=Forward, R=Reverse. a) Modified, b) Annealing site on S1in M41 reference strain of IBV (sequence accession number: AY851295).), 2 *µl* of cDNA, in a final volume of 20 *µl*. The amplification reaction included a preincubation step at 95°C for 8 min to activate the HotStart Taq DNA polymerase, followed by 40 cycles of amplification including denaturation at 95 for 30 sec, annealing at 49.2°C for 30 sec and extension at 72°C for 30 sec \[[@r27]\]. After amplification by RT-qPCR, a melting analysis curve was performed by raising the incubation temperature from 65 to 95°C in 0.1°C increments with a hold of 1 sec at each increment.

The analytical specificity of RT-qPCR was assessed using three non-related RNA viruses including Newcastle disease virus (NDV, La Sota vaccine strain), infectious bursal disease (IBDV, Lukert vaccine strain) and avian metapneumovirus (AMPV, PL-21 vaccine strain).

The analytical sensitivity of RT-qPCR was assessed using seven serial ten-fold dilutions of plasmidial DNA containing the *orf* of S1 gene fragment (1.6 kb) of M41 strain of IBV cloned into the PYES 2.1/v5--His TOPO vector (Invitrogen), using two combinations of oligonucleotides to evaluate the analytical sensitivity. Cq (Cycle quantification) results were used to calculate the Log of IBV copies (Log10) using linear equation from a standard curve. The reproducibility was determined by testing in duplicate and in four independent runs, followed by calculation of mean, standard deviation (S.D.) and coefficient of variation (C.V.).

Tm data of the real-time RT-PCR assay was analyzed statistically by the Scott-Knott test \[[@r30]\], and the level of significance was set at *P*≤0.05.

The detection limit of RT-qPCR was 1.32 × 10^2^ copies, *R^2^*=0.997, efficiency=93.06% ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Results obtained from analytical sensitivity test of RT-qPCR for IBV detection using tenfold serial dilutions of plasmidial DNA containing the S1 gene of M41 strain of IBV (10^−1^ to 10^−9^): \[A\] Amplification curves from RT-qPCR, \[B\] Dissociation curves RT-qPCR, \[C\] Electrophoresis analysis of amplified products from the dilutions of plasmidial DNA: (M) −100 bp ladder (Invitrogen), (lanes 1 to 9 correspond to dilutions 10^−1^ to 10^−9^).). The reproducibility ranged from 0.1575 to 0.7585 cycles, while the C.V. inter-assay ranged from 0.56 to 2.64%. All IBV strains were successfully detected and no positive signal was recorded for the three non-related avian RNA-viruses tested.

The RT-qPCR developed in this study detected the virus in tracheal samples from birds experimentally infected with M41, or with H120 strains, in the period from 1 to 20 dpi (entire post-infection period evaluated) or from 3 to 12 dpi, respectively, while in pulmonary samples IBV detection varied from 8 to 15 dpi, or only at 3 dpi in M41-infected or H120-infected birds, respectively. Conversely, the standard method of virus isolation in SPF embryonated eggs detected the virus only from 2 to 9 dpi or at 3 dpi for both types of tissue samples from birds infected with M41 or H120, respectively. No positive signal of amplification and no positive results by virus isolation were found in tissues samples from negative control birds ([Table 3](#tbl_003){ref-type="table"}Table 3.Virus detection in pulmonary and tracheal samples from experimentally infected chickens (M41 or H120 strains) by RT-qPCR and virus isolation methodsChallengeRT-qPCRVILungM4111/148/14TracheaM4114/148/14LungH1201/31/3TracheaH1203/31/3LungMock infected0/140/14TracheaMock infected0/140/14Birds of same group/interval (3 biological replicates) were pooled and processed as one sample by both RT-qPCR and VI.).

The absence of amplification signal in other non-related RNA viruses and in negative control samples, characterized the specificity of RT-qPCR.

All tested IBV strains were amplified by RT-qPCR using both primer sets (HVR I and HVR II). Amplicons of expected size for S1 gene of IBV using HVR I or HVR II primer sets were also visualized by gel electrophoresis analysis. In the first-derivative melting curve analysis, the S1 gene amplicons displayed melting temperature (Tm) values ranging from 80.30 to 83.70°C, for HVR I amplicons, and from 76.16 to 78.25°C for HVR II amplicons.

All Mass related IBV strains (reference strains and field isolates) tested in this study presented the same Tm profile (81.38 ± 0.28°C) for melting temperature analysis of HVR I amplicons, as no significant differences were observed, while all the remaining tested strains presented significant differences in their Tm profiles ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Dissociation curves obtained from RT-qPCR products using primers flanking HVRI region of S1 of IBV from different IBV strain tested.). Interestingly, the IBVPR05 strain, showed two melting peaks, with the highest peak at 83.17°C, and another one at the same Tm profile as Mass group ([Fig. 2](#fig_002){ref-type="fig"}). We hypothesized that this sample of Brazilian field isolate was composed by two populations or *quasispecies*, as described previously \[[@r17]\] for a sample of Beaudette strain of IBV amplified by RT-qPCR using another pair of primers.

However, when the melting temperature analysis was performed using HVR II region, the Mass genotype differentiation was not possible, though the Tm profiles for HVR II amplicons of JMK and SE-17 strains and one Brazilian variant isolate (IBVPR05) were distinct one each other and from the remaining tested IBV strains. A similar distinction was observed in the Tm profile of HVR II amplicon for M41 strain with regard to H120 strain, in spite of these viruses are classified in the Massachusetts genotype.

The detection limit of our method is similar to that recorded for a real-time PCR assay based on 5′-UTR gene of IBV genome \[[@r3]\]. However our assay is less sensitive than another real-time technique targeting an ORF1b of replicase gene of IBV \[[@r11]\]. This difference might be due to the fact that targeting the most conserved and abundant genes of coronavirus, like replicase gene or nucleoprotein gene, can enhance the sensitivity of conventional and RT-qPCR methods \[[@r2], [@r11], [@r24]\]. Nonetheless, more conserved target genes do not allow differentiation between different genotypes of IBV \[[@r24]\], as S1 gene RT-PCR does, which remains an important tool for genotyping IBV isolates.

There are several reports demonstrating the use of melting temperature analysis to differentiate genotypes of virus pathogens \[[@r4], [@r20], [@r29], [@r31], [@r32]\]. Similarly, the method used here provided differentiation of Mass genotype using HVR I region, as all tested strains previously genotyped belonging to Mass genotype presented no significant different Tm values, while the other strains previously genotyped differently from Mass presented significant different Tm values ([Table 1](#tbl_001){ref-type="table"}). In addition, previous study \[[@r16]\] using primers flanking similar HVRs of S1 gene in RT-qPCR with EVAGREEN succeeded in discriminating IBV strains from Taiwan and H120 from M41 strain of IBV.

Currently, IBV genotype differentiation has been performed using separated molecular assays, which have increased both time and cost. Assays for genotyping based on conventional molecular methods such as PCR, RFLP, hybridization assay and direct sequencing are time-consuming, more complex and expensive. Alternatively, the method described here has allowed simultaneous detection of IBV genome and Mass genotype identification in a single reaction. The specificity of Mass genotyping by our method was confirmed, comparing with the results obtained previously \[[@r21], [@r26]\].

In conclusion, the method described here provides a practical and effective screening test for simultaneous detection and Mass genotyping of IBV. Moreover, this rapid, simple, specific and sensitive test is applicable for both IBV previously isolated and directly in clinical samples.
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